News

Under the contract, Maxwell will fund the Phase I and II human clinical studies of AHRO-001 in Russia. In return, AtheroNova will issue up to $4.1m in common

The recommendation is based on the results from a double-blind Rocket AF Phase 3 trial which showed that once-daily rivaroxaban had a 21% relative risk reduction in stroke

The aim of the trial is to compare the objective response rate (ORR) of carboplatin and paclitaxel with or without bavituximab in up to 86 patients with previously

Following the acquisition, Amira has become the wholly-owned subsidiary of BMS. Earlier in July 2011, BMS signed a definitive agreement to acquire Amira for $325m. The deal allowed

The 4 gigabyte test submission comprising chemistry, manufacturing and control (CMC), preclinical and clinical data was reviewed, validated and approved without errors and in record time. Regulatory Services

The dietary supplements include Omega-3, Probiotic, and Fruit & Veggie. Omega-3 provides two Omega-3s (according to Eicosapentaenoic Acid/EPA and Docosahexaenoic Acid/DHA standards) in an ultra-concentrated MiniGel. Omega-3, due

Under the terms of the agreement, LabCorp will continue to be the national laboratory for UnitedHealthcare and Oxford Health Plans. The company will be the laboratory provider for

Pantoprazole Sodium Delayed Release Tablets 20mg & 40mg are the generic version of Protonix of Wyeth. Pantoprazole Sodium tablets are indicated for the short-term treatment of erosive esophagitis

McBean served at Covidien’s Specialty Pharmaceuticals as vice president and general manager from March 2009 until May 2011 and was responsible for executing a successful turnaround of the